Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Narrative Review

Vol. 5 No. 2 (1999)

HIV in the Developing World - Meeting the Challenge of the Growing Dichotomy

  • Bhargavi Rao, M.B. B.Ch., M.A. (Hons)
DOI
https://doi.org/10.26443/mjm.v5i2.572
Submitted
November 7, 2020
Published
2020-12-01

Abstract

N/A

References

  1. Camus A. The Plague. Harmondsworth, England: Penguin Books Ltd; 1973.
  2. Horton R. The 12th World AIDS Conference: a cautionary tale. Lancet 352: 122; 1998.
  3. AIDS Epidemic Update: December 1999. UNAIDS/WHO.
  4. http://www.unaids.org/publications/documents/epidemiology/surveillance/wad1999/embaee.pdf. 1999.
  5. Mulder DW, Nunn AJ, Kamali A, et al. Two year HIV-1 associated mortality in an Ugandan rural population. Lancet
  6. : 1021-1023; 1994.
  7. Kumar S. India has the largest number of people infected with HIV. Lancet 353: 48; 1999.
  8. Newell ML. European Collaborative Study - Risk Factors for Vertical Transmission. European Collaborative Study Conference Report 6-13; 1992.
  9. Rao VB. The use of AZT to reduce the risk of vertical transmission of HIV-1. McGill Journal of Medicine 4: 38-45;
  10. Abdool QK. Epidemiology of HIV infection - new and emerging epidemics. 12th World AIDS Conference June 1998
  11. (webcast.aids98.org).
  12. Carael M, Schwartlander B, Zewdie D. Editorial and Introduction. AIDS 12 (suppl 1): S1-S2; 1998.
  13. Trollope A. Framley Parsonage. London: G. Bell and Sons; 1914.
  14. Heath I, Haines A. Joining the fight against poverty: open invitation from the International Poverty and Health Network to all health professionals. McGill Journal of Medicine 5: 118-120; 2000.
  15. Decosas J. HIV and development. AIDS 10 (suppl 3): S69 - S74; 1996.
  16. Gilks CF. Tropical Medicine in the HIV/AIDS era. Lancet 349 (suppl 3): 17-19; 1997.
  17. Harries AD, Mather D. TB/HIV - a clinical manual (WHO/TB/96.2000) Geneva: WHO Global TB Programme; 1996.
  18. Quinn TC. Global burden of the HIV pandemic. Lancet 348: 99-105; 1996.
  19. The World Bank World Development Report. Investing in Health. London: Oxford University Press; 1993.
  20. Chin HJ. Current and future dimensions of the HIV/AIDS pandemic in women and children. Lancet 336: 221-224; 1990.
  21. Baggaley RC, Needham D. Africa’s emerging AIDS-orphans crisis. Canadian Medical Association Journal 156: 873-875; 1997.
  22. Grant JM. Tropical disease, the hydra technology will not slay. McGill Journal of Medicine 5: 127-132; 2000.
  23. Msamanga GI, Fawzi WW. The double burden of HIV infection and tuberculosis in Sub-Saharan Africa. New England Journal of Medicine 337: 849-851; 1997.
  24. Barnett T, Blaikie P. AIDS in Africa: Its Present and Future Impact. London: Belhaven Press; 1992.
  25. Topouzis D. Overview of the sub-regional and national workshops on the effect of HIV/AIDS on agricultural production systems and rural livelihoods. UN Food and Agricultural Organisation 1994. (as quoted in 9)
  26. Editorial. A growing dichotomy: the gap between therapeutic haves and have-nots. AIDS Alert 13: 1-4; 1997.
  27. Report on the Global HIV/AIDS Epidemic - June 1998. Geneva: UNAIDS and WHO; 1998.
  28. Editorial. Looking forward to the back of HIV. Nature Medicine 4: 867-868; 1998.
  29. Morris L, Martin DJ, Quinn TC, et al. The importance of doing HIV research in developing countries. Nature Medicine 4: 1228-1229; 1998.
  30. Adler MW. Antiretrovirals for the developing world. Lancet 351: 232; 1998.
  31. Arya SC. Antiretroviral therapy in countries with low health expenditure. Lancet 351: 1433-1434; 1998.
  32. d’Cruz-Grote D. Prevention of HIV infection in developing countries. Lancet 348: 1071-1074; 1996.
  33. Lalwani A, Shastri JS. HIV epidemic in India: opportunity to learn from the past. Lancet 347: 1349-1350; 1996.
  34. Carballo M, Kenya PI. Behavioural issues and AIDS. In: Essex M, ed. AIDS in Africa. Raven Press; 1994: 497-512.
  35. Wilkinson D. Syndromic management of STDs in developing countries: what role in the control of the STD and HIV epidemics? Genitourinary Medicine 73: 427-428; 1997.
  36. Grant AD, De Cock KM. The growing challenge of HIV/AIDS in developing countries. British Medical Bulletin 54: 369-381;
  37. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of STDs on HIV infection in rural Tanzania: randomised controlled trial. Lancet 364: 530-536; 1995.
  38. Nelson KE, Celentano DD, Eiumtrakol S, et al. Changes in sexual behaviour and decline in HIV infection among young
  39. men in Thailand. New England Journal of Medicine 335: 297-303; 1996.
  40. Robinson NJ, Silarug N, Surasiengsunk S, et al. Two million HIV infections prevented in Thailand: estimate of the impact of increased condom use. XI International Conference on AIDS, Vancouver, 1996. (Abstract MoC904)
  41. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of the human immunodeficiency virus type 1 with zidovudine treatment. New England Journal of Medicine 331: 1173-1180; 1994.
  42. Administration of Zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission – Thailand, 1996 – 1998. Morbidity and Mortality Weekly Report 47: 151-154; 1998.

Downloads

Download data is not yet available.

Similar Articles

1 2 3 > >> 

You may also start an advanced similarity search for this article.